Indian Immunologicals receive manufacturing license for Covaxin drug substance
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
The company reported total income Rs.18.57 crores during the period ended June 30, 2020.
The Macau authorization followed a regulatory review that considered prior decisions by both the US FDA) and the European Medicines Agency
The company plans to submit the vaccine for regulatory review
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
These approvals represent a defining moment for people living with classical Hodgkin Lymphoma
The kit features ViaPlex 405 Barcoding Dye for the 405 nm laser/Pacific Blue filter and ViaPlex 488 Barcoding Dye for the 488 nm laser/FITC filter
AstraZeneca says the approval strengthens its push to bring immunotherapy earlier into cancer treatment, where long-term cures are possible
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
Subscribe To Our Newsletter & Stay Updated